Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger's disease

Circulation Journal

Volumn 71, Issue 8, 2007, Pages 1187-1192

  Saito, Yutaka ^a   Sasaki, Ken Ichiro ^a   Katsuda, Yousuke ^a   Murohara, Toyoaki ^b   Takeshita, Yoshiaki ^a   Okazaki, Teiji ^a   Arima, Ken ^a   Katsuki, Yoshio ^a   Shintani, Satoshi ^b   Shimada, Toshifumi ^a   Akashi, Hidetoshi ^a   Ikeda, Hisao ^a   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone marrow; Buerger's disease; Cell therapy; Ischemia; Skin ulcer

Indexed keywords

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BUERGER DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; HUMAN; MALE; MUSCLE ISCHEMIA; PERIPHERAL OCCLUSIVE ARTERY DISEASE; SKIN ULCER; TREATMENT OUTCOME; ULCER HEALING; VISUAL ANALOG SCALE;

ADULT; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PAIN; THROMBOANGIITIS OBLITERANS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; ULCER;

EID: 34547597418     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.1187     Document Type: Article

References (24)

1. Olin JW. Thromboangiitis obliterans (Buerger's disease). N Engl J Med 2000; 343: 864-869.
2. Olin JW, Young JR, Graor RA, Ruschhaupt WF, Bartholomew JR. The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease). Circulation 1990; 82: IV-3-IV-8.
3. Lau H, Cheng SW. Buerger's disease in Hong Kong: A review of 89 cases. Aust NZ J Surg 1997; 67: 264-269.
4. Fiessinger JN, Schafer M. Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans: The TAO Study. Lancet 1990; 335: 555-557.
5. Hussein EA, el Dorri A. Intra-arterial streptokinase as adjuvant therapy for complicated Buerger's disease: Early trials. Int Surg 1993; 78: 54-58.
6. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: A pilot study and a randomised controlled trial. Lancet 2002; 360: 427-435.
7. Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet 1978; 2: 654-657.
8. Levine JD, Gordon NC, Bornstein JC, Fields HL. Role of pain in placebo analgesia. Proc Natl Acad Sci USA 1979; 76: 3528-3531.
9. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 653-660.
10. Rajagopalan S, Mohler ER 3rd, Lederman RJ, Mendelsohn FO, Saucedo JF, Goldman CK, et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: A phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 2003; 108: 1933-1938.
11. Morishita R, Aoki M, Hashiya N, Makino H, Yamasaki K, Azuma J, et al. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 2004; 44: 203-209.
12. Isner JM, Baumgartner I, Rauh G, Schainfeld R, Blair R, Manor O, et al. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: Preliminary clinical results. J Vasc Surg 1998; 28: 964-973; discussion 973-965.
13. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
14. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434-438.
15. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-228.
16. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000; 97: 3422-3427.
17. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000; 105: 1527-1536.
18. Shintani S, Murohara T, Ikeda H, Ueno T, Sasaki K, Duan J, et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 2001; 103: 897-903.
19. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6: 389-395.
20. Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, Ozono R, et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001; 104: 1046-1052.
21. Shyu KG, Manor O, Magner M, Yancopoulos GD, Isner JM. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation 1998; 98: 2081-2087.
22. Qin SL, Li TS, Takahashi M, Hamano K. In vitro assessment of the effect of interleukin-1beta on angiogenic potential of bone marrow cells. Circ J 2006; 70: 1195-1199.
23. Takakura N, Watanabe T, Suenobu S, Yamada Y, Noda T, Ito Y, et al. A role for hematopoietic stem cells in promoting angiogenesis. Cell 2000; 102: 199-209.
24. Ishida A, Ohya Y, Sakuda H, Ohshiro K, Higashiuesato Y, Nakaema M, et al. Autologous peripheral blood mononuclear cell implantation for patients with peripheral arterial disease improves limb ischemia. Circ J 2005; 69: 1260-1265.